Neuroprotective mechanisms of taurine against ischemic stroke

Brain Sciences

Volumn 3, Issue 2, 2013, Pages 877-907

  Menzie, Janet ^a,b   Prentice, Howard ^b   Wu, Jang Yen ^a,b  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Clinical trial; Endoplasmic reticulum stress; Glutamate excitotoxicity; Inflammation; Ischemic stroke; Mitochondrial dysfunction; Neuroprotective mechanisms; Oxidative stress; Taurine

Indexed keywords

CALPAIN; CASPASE 12; CASPASE 3; CASPASE 8; CASPASE 9; GLUCOSE REGULATED PROTEIN 78; GLUTAMIC ACID; GLUTATHIONE PEROXIDASE; HEMOSIDERIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN BCL 2; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; RYANODINE RECEPTOR; TAURINE; VESICULAR GLUTAMATE TRANSPORTER 1;

ANAEROBIC METABOLISM; ANTIOXIDANT ACTIVITY; APOPTOSIS; BRAIN DAMAGE; BRAIN ISCHEMIA; CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONSCIOUSNESS; CYTOTOXICITY; EDEMA; ELECTRIC ACTIVITY; ENDOPLASMIC RETICULUM STRESS; EXCITOTOXICITY; HEART LEFT VENTRICLE FUNCTION; HUMAN; INCIDENCE; INFLAMMATION; MELAS SYNDROME; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; RESPIRATORY CHAIN; REVIEW; UNFOLDED PROTEIN RESPONSE;

EID: 84904395526     PISSN: None     EISSN: 20763425     Source Type: Journal    
DOI: 10.3390/brainsci3020877     Document Type: Review

References (254)

1. Feigin, V.L.; Lawes, C.M.M.; Bennett, D.A.; Barker-Collo, S.L.; Parag, V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol. 2009, 8, 355-369.
2. Strong, K.; Mathers, C.; Bonita, R. Preventing stroke: Saving lives around the world. Lancet Neurol. 2007, 6, 182-187.
3. MacKay, J.; Mensah, G. The Atlast of Heart Disease and Stroke; World Health Organization: Geneva, Switzerland, 2004; pp. 50-53.
4. Tackling the global burden of stroke. Lancet Neurol. 2005, 4, 689.
5. Rosamond, W.; Flegal, K.; Friday, G.; Furie, K.; Go, A.; Greenlund, K.; Haase, N.; Ho, M.; Howard, V.; Kissela, B.; et al. Heart disease and stroke statistics-2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115, 169-171.
6. Kirino, Y.; Yasukawa, T.; Ohta, S.; Akira, S.; Ishihara, K.; Watanabe, K.; Suzuki, T. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc. Natl. Acad. Sci. USA 2004, 101, 15070-15075.
7. Busl, K.M.; Greer, D.M. Hypoxic-ischemic brain injury: Pathophysiology, neuropathology and mechanims. NeuroRehabilitation 2010, 26, 5-13.
8. Hossmann, K.A. Pathophysiology and therapy of experimental stroke. Cell. Mol. Neurobiol. 2006, 26, 1057-1083.
9. Hossmann, K.A. Viability thresholds and the penumbra of focal ischemia. Ann. Neurol. 1994, 36, 557-565.
10. Heiss, W.D.; Grond, M.; Thiel, A.; Von Stockhausen, H.M.; Rudolf, J.; Ghaemi, M.; Löttgen, J.; Stenzel, C.; Pawlik, G. Tissue at risk of infarction rescued by early reperfusion: A positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J. Cereb. Blood Flow Metab. 1998, 18, 1298-1307.
11. Obrenovitch, T.P. The ischaemic penumbra: Twenty years on. Cerebrovasc. Brain Metab. Rev. 1995, 7, 297-323.
12. Fisher, M.; Garcia, J.H. Evolving stroke and the ischemic penumbra. Neurology 1996, 47, 884-888.
13. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Tissue Plasminogen Activator for Acute Ischemic Stroke. N. Engl. J. Med. 1995, 333, 1581-1588.
14. Hacke, W.; Kaste, M.; Bluhmki, E.; Brozman, M.; Dávalos, A.; Guidetti, D.; Larrue, V.; Lees, K.R.; Medeghri, Z.; Machnig, T.; et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 2008, 359, 1317-1329.
15. Jacobsen, J.G.; Smith, L.H. Biochemistry and physiology of taurine and taurine derivatives. Physiol. Rev. 1968, 48, 424-511.
16. Reichelt, K.L.; Edminson, P.D. Biogenic amine specificity of cortical peptide synthesis in monkey brain. FEBS Lett. 1974, 47, 185-189.
17. Macaione, S.; Ruggeri, P.; De Luca, F.; Tucci, G. Free Amino Acids in Developing Rat Retina. J. Neurochem. 1974, 22, 887-891.
18. Huxtable, R.J. Metabolism and function of taurine in the heart. In Taurine; Raven Press: New York, NY, USA, 1976; pp. 99-119.
19. Huxtable, R.J. Physiological actions of taurine. Physiol. Rev. 1992, 72, 101-163.
20. Saransaari, P.; Oja, S.S. Taurine and neural cell damage. Amino Acids 2000, 19, 509-526.
21. Warskulat, U.; Flögel, U.; Jacoby, C.; Hartwig, H.-G.; Thewissen, M.; Merx, M.W.; Molojavyi, A.; Heller-Stilb, B.; Schrader, J.; Häussinger, D. Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J. 2004, 18, 577-579.
22. Oja, S.S.; Saransaari, P. Pharmacology of Taurine. Proc. West. Pharmacol. Soc. 2007, 50, 8-15.
23. Wu, J.Y. Purification and characterization of cysteic acid and cysteine sulfinic acid decarboxylase and L-glutamate decarboxylase from bovine brain. Proc. Natl. Acad. Sci. USA 1982, 79, 4270-4274.
24. Hayes, K.C. Taurine requirement in primates. Nutr. Rev. 1985, 43, 65-70.
25. Stapleton, P.P.; Charles, R.P.; Redmond, H.P.; Bouchier-Hayes, D.J. Taurine and human nutrition. Clin. Nutr. 1997, 16, 103-108.
26. Yamori, Y.; Taguchi, T.; Hamada, A.; Kunimasa, K.; Mori, H.; Mori, M. Taurine in health and diseases: Consistent evidence from experimental and epidemiological studies. J. Biomed. Sci. 2010, 17, S6.
27. Curtis, D.R.; Watkins, J.C. The pharmacology of amino acids related to gamma-aminobutyric acid. Pharmacol. Rev. 1965, 17, 347-391.
28. Davison, A.N.; Kaczmarek, L.K. Taurine-a possible neurotransmitter? Nature 1971, 234, 107-108.
29. Hayes, K.C.; Carey, R.E.; Schmidt, S.Y. Retinal degeneration associated with taurine deficiency in the cat. Science 1975, 188, 949-951.
30. Imaki, H.; Jacobson, S.G.; Kemp, C.M.; Knighton, R.W.; Neuringer, M.; Sturman, J. Retinal morphology and visual pigment levels in 6-and 12-month-old rhesus monkeys fed a taurine-free human infant formula. J. Neurosci. Res. 1993, 36, 290-304.
31. Militante, J.D.; Lombardini, J.B. Taurine: Evidence of physiological function in the retina. Nutr. Neurosci. 2002, 5, 75-90.
32. Bulley, S.; Liu, Y.; Ripps, H.; Shen, W. Taurine activates delayed rectifier KV channels via a metabotropic pathway in retinal neurons. J. Physiol. 2013, 591, 123-132.
33. Ito, T.; Kimura, Y.; Uozumi, Y.; Takai, M.; Muraoka, S.; Matsuda, T.; Ueki, K.; Yoshiyama, M.; Ikawa, M.; Okabe, M.; Schaffer, S.W.; Fujio, Y.; Azuma, J. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J. Mol. Cell. Cardiol. 2008, 44, 927-937.
34. Schaffer, S.W.; Jong, C.J.; Ramila, K.C.; Azuma, J. Physiological roles of taurine in heart and muscle. J. Biomed. Sci. 2010, 17, S2.
35. Sturman, J.A. Taurine in Development. Physiol. Rev. 1993, 73, 119-147.
36. L'Amoreaux, W.J.; Cuttitta, C.; Santora, A.; Blaize, J.F.; Tachjadi, J.; El Idrissi, A. Taurine regulates insulin release from pancreatic beta cell lines. J. Biomed. Sci. 2010, 17, S11.
37. Sturman, J.A.; Moretz, R.C.; French, J.H.; Wisniewski, H.M. Taurine deficiency in the developing cat: Persistence of the cerebellar external granule cell layer. J. Neurosci. Res. 1985, 13, 405-416.
38. Sturman, J.A.; Moretz, R.C.; French, J.H.; Wisniewski, H.M. Postnatal taurine deficiency in the kitten results in a persistence of the cerebellar external granule cell layer: Correction by taurine feeding. J. Neurosci. Res. 1985, 13, 521-528.
39. Neuringer, M.; Palackal, T.; Kujawa, M.; Moretz, R.C.; Sturman, J.A. Visual cortex development in rhesus monkeys deprived of dietary taurine. Prog. Clin. Biol. Res. 1990, 351, 415-422.
40. Hernández-Benítez, R.; Pasantes-Morales, H.; Saldaña, I.T.; Ramos-Mandujano, G. Taurine stimulates proliferation of mice embryonic cultured neural progenitor cells. J. Neurosci. Res. 2010, 88, 1673-1681.
41. Hernández-Benítez, R.; Ramos-Mandujano, G.; Pasantes-Morales, H. Taurine stimulates proliferation and promotes neurogenesis of mouse adult cultured neural stem/progenitor cells. Stem Cell Res. 2012, 9, 24-34.
42. Bianchi, L.; Colivicchi, M.A.; Ballini, C.; Fattori, M.; Venturi, C.; Giovannini, M.G.; Healy, J.; Tipton, K.F.; Della Corte, L. Taurine, taurine analogues, and taurine functions: Overview. Adv. Exp. Med. Biol. 2006, 583, 443-448.
43. Ripps, H.; Shen, W. Review: Taurine: A "very essential" amino acid. Mol. Vis. 2012, 18, 2673-2686.
44. Anuradha, C.V.; Balakrishnan, S.D. Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can. J. Physiol. Pharmacol. 1999, 77, 749-754.
45. Nakaya, Y.; Minami, A.; Harada, N.; Sakamoto, S.; Niwa, Y.; Ohnaka, M. Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am. J. Clin. Nutr. 2000, 71, 54-58.
46. Ito, T.; Schaffer, S.W.; Azuma, J. The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 2012, 42, 1529-1539.
47. Murakami, S. Taurine and atherosclerosis. Amino Acids 2012, doi:10.1007/s00726-012-1432-6.
48. Menzie, J.; Pan, C.; Prentice, H.; Wu, J.-Y. Taurine and central nervous system disorders. Amino Acids 2012, doi:10.1007/s00726-012-1382-z.
49. Pion, P.D.; Kittleson, M.D.; Rogers, Q.R.; Morris, J.G. Myocardial failure in cats associated with low plasma taurine: A reversible cardiomyopathy. Science 1987, 237, 764-768.
50. Zulli, A. Taurine in cardiovascular disease. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14, 57-60.
51. Tsuji, A.; Tamai, I. Sodium-and chloride-dependent transport of taurine at the blood-brain barrier. Adv. Exp. Med. Biol. 1996, 403, 385-391.
52. Salimäki, J.; Scriba, G.; Piepponen, T.P.; Rautolahti, N.; Ahtee, L. The effects of systemically administered taurine and N-pivaloyltaurine on striatal extracellular dopamine and taurine in freely moving rats. Naunyn Schmiedebergs Arch. Pharmacol. 2003, 368, 134-141.
53. Huxtable, R.J. Taurine in the central nervous system and the mammalian actions of taurine. Prog. Neurobiol. 1989, 32, 471-533.
54. Wu, J.-Y.; Prentice, H. Role of taurine in the central nervous system. J. Biomed. Sci. 2010, 17, S1.
55. Kuriyama, K. Taurine as a neuromodulator. Fed. Proc. 1980, 39, 2680-2684.
56. El Idrissi, A.; Trenkner, E. Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem. Res. 2004, 29, 189-197.
57. Banerjee, R.; Vitvitsky, V.; Garg, S.K. The undertow of sulfur metabolism on glutamatergic neurotransmission. Trends Biochem. Sci. 2008, 33, 413-419.
58. Saransaari, P.; Oja, S.S. Taurine release in mouse brain stem slices under cell-damaging conditions. Amino Acids 2007, 32, 439-446.
59. Chen, W.Q.; Jin, H.; Nguyen, M.; Carr, J.; Lee, Y.J.; Hsu, C.C.; Faiman, M.D.; Schloss, J.V.; Wu, J.Y. Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons. J. Neurosci. Res. 2001, 66, 612-619.
60. Foos, T.M.; Wu, J.-Y. The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis. Neurochem. Res. 2002, 27, 21-26.
61. El Idrissi, A.; Trenkner, E. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J. Neurosci. 1999, 19, 9459-9468.
62. El Idrissi, A.; Trenkner, E. Taurine regulates mitochondrial calcium homeostasis. Adv. Exp. Med. Biol. 2003, 526, 527-536.
63. El Idrissi, A. Taurine increases mitochondrial buffering of calcium: Role in neuroprotection. Amino Acids 2008, 34, 321-328.
64. Moran, J.; Salazar, P.; Pasantes-Morales, H. Effect of tocopherol and taurine on membrane fluidity of retinal rod outer segments. Exp. Eye Res. 1987, 45, 769-776.
65. Hagar, H.H. The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol. Lett. 2004, 151, 335-343.
66. Schaffer, S.W.; Azuma, J.; Mozaffari, M. Role of antioxidant activity of taurine in diabetes. Can. J. Physiol. Pharmacol. 2009, 87, 91-99.
67. Miao, J.; Zhang, J.; Zheng, L.; Yu, X.; Zhu, W.; Zou, S. Taurine attenuates Streptococcus uberis-induced mastitis in rats by increasing T regulatory cells. Amino Acids 2012, 42, 2417-2428.
68. Sun, M.; Zhao, Y.; Gu, Y.; Xu, C. Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB. Amino Acids 2012, 42, 1735-1747.
69. Wu, H.; Jin, Y.; Wei, J.; Jin, H.; Sha, D.; Wu, J.-Y. Mode of action of taurine as a neuroprotector. Brain Res. 2005, 1038, 123-131.
70. Leon, R.; Wu, H.; Jin, Y.; Wei, J.; Buddhala, C.; Prentice, H.; Wu, J.-Y. Protective function of taurine in glutamate-induced apoptosis in cultured neurons. J. Neurosci. Res. 2009, 87, 1185-1194.
71. Junyent, F.; Romero, R.; de Lemos, L.; Utrera, J.; Camins, A.; Pallàs, M.; Auladell, C. Taurine treatment inhibits CaMKII activity and modulates the presence of calbindin D28k, calretinin, and parvalbumin in the brain. J. Neurosci. Res. 2010, 88, 136-142.
72. Pan, C.; Giraldo, G.S.; Prentice, H.; Wu, J.-Y. Taurine protection of PC12 cells against endoplasmic reticulum stress induced by oxidative stress. J. Biomed. Sci. 2010, 17, S17.
73. Pan, C.; Prentice, H.; Price, A.L.; Wu, J.-Y. Beneficial effect of taurine on hypoxia-and glutamate-induced endoplasmic reticulum stress pathways in primary neuronal culture. Amino Acids 2012, 43, 845-855.
74. Lima, L.; Cubillos, S. Taurine might be acting as a trophic factor in the retina by modulating phosphorylation of cellular proteins. J. Neurosci. Res. 1998, 53, 377-384.
75. Kontro, P.; Oja, S.S. Sodium-independent taurine binding to brain synaptic membranes. Cell. Mol. Neurobiol. 1983, 3, 183-187.
76. Wu, J.Y.; Moss, L.G.; Chen, M.S. Tissue and regional distribution of cysteic acid decarboxylase. A new assay method. Neurochem. Res. 1979, 4, 201-212.
77. Magnusson, K.R.; Clements, J.R.; Wu, J.Y.; Beitz, A.J. Colocalization of taurine-and cysteine sulfinic acid decarboxylase-like immunoreactivity in the hippocampus of the rat. Synapse 1989, 4, 55-69.
78. +. J. Neurosci. Res. 1989, 22, 167-171.
79. Martin, D.L. Synthesis and release of neuroactive substances by glial cells. Glia 1992, 5, 81-94.
80. Kozlowski, D.J.; Chen, Z.; Zhuang, L.; Fei, Y.J.; Navarre, S.; Ganapathy, V. Molecular characterization and expression pattern of taurine transporter in zebrafish during embryogenesis. Life Sci. 2008, 82, 1004-1011.
81. Kang, Y.-S. Downregulation of taurine transport by calcium blockers in osteoblast cells. Adv. Exp. Med. Biol. 2009, 643, 513-521.
82. Okamoto, K.; Kimura, H.; Sakai, Y. Taurine-induced increase of the Cl-conductance of cerebellar Purkinje cell dendrites in vitro. Brain Res. 1983, 259, 319-323.
83. Del Olmo, N.; Bustamante, J.; Del Río, R.M.; Solís, J.M. Taurine activates GABA(A) but not GABA(B) receptors in rat hippocampal CA1 area. Brain Res. 2000, 864, 298-307.
84. Albrecht, J.; Schousboe, A. Taurine interaction with neurotransmitter receptors in the CNS: An update. Neurochem. Res. 2005, 30, 1615-1621.
85. Wu, J.; Kohno, T.; Georgiev, S.K.; Ikoma, M.; Ishii, H.; Petrenko, A.B.; Baba, H. Taurine activates glycine and gamma-aminobutyric acid A receptors in rat substantia gelatinosa neurons. Neuroreport 2008, 19, 333-337.
86. Wu, J.Y.; Tang, X.W.; Tsai, W.H. Taurine receptor: Kinetic analysis and pharmacological studies. Adv. Exp. Med. Biol. 1992, 315, 263-268.
87. Frosini, M.; Sesti, C.; Saponara, S.; Ricci, L.; Valoti, M.; Palmi, M.; Machetti, F.; Sgaragli, G. A specific taurine recognition site in the rabbit brain is responsible for taurine effects on thermoregulation. Br. J. Pharmacol. 2003, 139, 487-494.
88. Astrup, J.; Siesjö, B.K.; Symon, L. Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 1981, 12, 723-725.
89. Kristian, T.; Siesjo, B.K. Calcium in ischemic cell death. Stroke 1998, 29, 705-718.
90. Martin, R.L.; Lloyd, H.G.; Cowan, A.I. The early events of oxygen and glucose deprivation: Setting the scene for neuronal death? Trends Neurosci. 1994, 17, 251-257.
91. Katsura, K.; Kristian, T.; Siesjo, B.K. Energy metabolism, ion homeostasis, and cell damage in the brain. Biochem. Soc. Trans. 1994, 22, 991-996.
92. Seki, Y.; Feustel, P.J.; Keller, R.W.; Tranmer, B.I.; Kimelberg, H.K.; Robinson, S.E. Inhibition of Ischemia-Induced Glutamate Release in Rat Striatum by Dihydrokinate and an Anion Channel Blocker Editorial Comment. Stroke 1999, 30, 433-440.
93. Globus, M.Y.-T.; Busto, R.; Dietrich, W.D.; Martinez, E.; Valdes, I.; Ginsberg, M.D. Effect of Ischemia on the in Vivo Release of Striatal Dopamine, Glutamate, and γ-Aminobutyric Acid Studied by Intracerebral Microdialysis. J. Neurochem. 1988, 51, 1455-1464.
94. Hillered, L.; Hallström, A.; Segersvärd, S.; Persson, L.; Ungerstedt, U. Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. J. Cereb. Blood Flow Metab. 1989, 9, 607-616.
95. Butcher, S.P.; Bullock, R.; Graham, D.I.; McCulloch, J. Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke 1990, 21, 1727-1733.
96. Yang, G.Y.; Betz, A.L. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 1994, 25, 1658-1664.
97. O'Regan, M.H.; Smith-Barbour, M.; Perkins, L.M.; Phillis, J.W. A possible role for phospholipases in the release of neurotransmitter amino acids from ischemic rat cerebral cortex. Neurosci. Lett. 1995, 185, 191-194.
98. O'Regan, M.H.; Perkins, L.M.; Phillis, J.W. Arachidonic acid and lysophosphatidylcholine modulate excitatory transmitter amino acid release from the rat cerebral cortex. Neurosci. Lett. 1995, 193, 85-88.
99. Phillis, J.W.; Song, D.; O'Regan, M.H. Inhibition by anion channel blockers of ischemia-evoked release of excitotoxic and other amino acids from rat cerebral cortex. Brain Res. 1997, 758, 9-16.
100. Rutledge, E.M.; Aschner, M.; Kimelberg, H.K. Pharmacological characterization of swelling-induced D-[3H]aspartate release from primary astrocyte cultures. Am. J. Physiol. Cell Physiol. 1998, 274, 1511-1520.
101. Feustel, P.J.; Jin, Y.; Kimelberg, H.K. Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra. Stroke 2004, 35, 1164-1168.
102. Szatkowski, M.; Barbour, B.; Attwell, D. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 1990, 348, 443-446.
103. Rossi, D.J.; Oshima, T.; Attwell, D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000, 403, 316-321.
104. Reuter, H.; Philipson, K.D. Sodium-calcium exchanger overexpression in the heart-insights from a transgenic mouse model. Basic Res. Cardiol. 2002, 97, 131-135.
105. Meldrum, B.S. Glutamate as a Neurotransmitter in the Brain: Review of Physiology and Pathology. J. Nutr. 2000, 130, 1007S-1015S.
106. Kwak, S.; Weiss, J.H. Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr. Opin. Neurobiol. 2006, 16, 281-287.
107. Berridge, M.J. Inositol Trisphosphate and Calcium Signaling. Ann. N. Y. Acad. Sci. 1995, 766, 31-43.
108. Sukhareva, M.; Smith, S.V.; Maric, D.; Barker, J.L. Functional Properties of Ryanodine Receptors in Hippocampal Neurons Change during Early Differentiation in Culture. J. Neurophysiol. 2002, 88, 1077-1087.
109. Paschen, W.; Mengesdorf, T. Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium 2005, 38, 409-415.
110. Ding, D.; Moskowitz, S.I.; Li, R.; Lee, S.B.; Esteban, M.; Tomaselli, K.; Chan, J.; Bergold, P.J. Acidosis induces necrosis and apoptosis of cultured hippocampal neurons. Exp. Neurol. 2000, 162, 1-12.
111. Yermolaieva, O.; Leonard, A.S.; Schnizler, M.K.; Abboud, F.M.; Welsh, M.J. Extracellular acidosis increases neuronal cell calcium by activating acid-sensing ion channel 1a. Proc. Natl. Acad. Sci. USA 2004, 101, 6752-6757.
112. Araújo, I.M.; Verdasca, M.J.; Leal, E.C.; Bahr, B.A.; Ambrósio, A.F.; Carvalho, A.P.; Carvalho, C.M. Early calpain-mediated proteolysis following AMPA receptor activation compromises neuronal survival in cultured hippocampal neurons. J. Neurochem. 2004, 91, 1322-1331.
113. Montague, J.; Gaido, M.; Frye, C.; Cidlowski, J. A calcium-dependent nuclease from apoptotic rat thymocytes is homologous with cyclophilin. Recombinant cyclophilins A, B, and C have nuclease activity. J. Biol. Chem. 1994, 269, 18877-18880.
114. Farooqui, A.A.; Yang, H.-C.; Rosenberger, T.A.; Horrocks, L.A. Phospholipase A2 and Its Role in Brain Tissue. J. Neurochem. 2002, 69, 889-901.
115. +: Implications for Neurodegeneration. J. Neurochem. 2002, 63, 584-591.
116. Lièvre, V.; Becuwe, P.; Bianchi, A.; Bossenmeyer-Pourié, C.; Koziel, V.; Franck, P.; Nicolas, M.; Dauça, M.; Vert, P.; Daval, J. Intracellular generation of free radicals and modifications of detoxifying enzymes in cultured neurons from the developing rat forebrain in response to transient hypoxia. Neuroscience 2001, 105, 287-297.
117. 2+-dependent generation of mitochondrial reactive oxygen species serves as a signal for poly(ADP-ribose) polymerase-1 activation during glutamate excitotoxicity. J. Physiol. 2007, 585, 741-758.
118. Lipton, P. Ischemic Cell Death in Brain Neurons. Physiol. Rev. 1999, 79, 1431-1568.
119. Nakka, V.P.; Gusain, A.; Mehta, S.L.; Raghubir, R. Molecular mechanisms of apoptosis in cerebral ischemia: Multiple neuroprotective opportunities. Mol. Neurobiol. 2008, 37, 7-38.
120. Pellegrini-Giampietro, D.E. The distinct role of mGlu1 receptors in post-ischemic neuronal death. Trends Pharmacol Sci. 2003, 24, 461-470.
121. Yamori, Y.; Liu, L.; Mori, M.; Sagara, M.; Murakami, S.; Nara, Y.; Mizushima, S. Taurine as the nutritional factor for the longevity of the Japanese revealed by a world-wide epidemiological survey. Adv. Exp. Med. Biol. 2009, 643, 13-25.
122. Wu, J.Y.; Lin, C.T.; Johansen, F.F.; Liu, J.W. Taurine neurons in rat hippocampal formation are relatively inert to cerebral ischemia. Adv. Exp. Med. Biol. 1994, 359, 289-298.
123. Schurr, A.; Rigor, B.M. The mechanism of neuronal resistance and adaptation to hypoxia. FEBS Lett. 1987, 224, 4-8.
124. Matsumoto, K.; Lo, E.H.; Pierce, A.R.; Halpern, E.F.; Newcomb, R. Secondary elevation of extracellular neurotransmitter amino acids in the reperfusion phase following focal cerebral ischemia. J. Cereb. Blood Flow Metab. 1996, 16, 114-124.
125. Torp, R.; Andiné, P.; Hagberg, H.; Karagülle, T.; Blackstad, T.W.; Ottersen, O.P. Cellular and subcellular redistribution of glutamate-, glutamine-and taurine-like immunoreactivities during forebrain ischemia: A semiquantitative electron microscopic study in rat hippocampus. Neuroscience 1991, 41, 433-447.
126. Uchiyama-Tsuyuki, Y.; Araki, H.; Yae, T.; Otomo, S. Changes in the Extracellular Concentrations of Amino Acids in the Rat Striatum During Transient Focal Cerebral Ischemia. J. Neurochem. 2008, 62, 1074-1078.
127. Lo, E.; Pierce, A.; Matsumoto, K.; Kano, T.; Evans, C.; Newcomb, R. Alterations in K+ evoked profiles of neurotransmitter and neuromodulator amino acids after focal ischemia-reperfusion. Neuroscience 1997, 83, 449-458.
128. Oja, S.S.; Saransaari, P. Modulation of taurine release by glutamate receptors and nitric oxide. Prog. Neurobiol. 2000, 62, 407-425.
129. Barakat, L.; Wang, D.; Bordey, A. Carrier-mediated uptake and release of taurine from Bergmann glia in rat cerebellar slices. J. Physiol. 2002, 541, 753-767.
130. Büyükuysal, R.L. Ischemia and reoxygenation induced amino acid release and tissue damage in the slices of rat corpus striatum. Amino Acids 2004, 27, 57-67.
131. Saransaari, P.; Oja, S.S. Modulation of taurine release in ischemia by glutamate receptors in mouse brain stem slices. Amino Acids 2010, 38, 739-746.
132. Fariello, R.G.; Golden, G.T.; Pisa, M. Homotaurine (3 aminopropanesulfonic acid; 3APS) protects from the convulsant and cytotoxic effect of systemically administered kainic acid. Neurology 1982, 32, 241-245.
133. French, E.D.; Vezzani, A.; Whetsell, W.O.; Schwarcz, R. Anti-excitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro. Adv. Exp. Med. Biol. 1986, 203, 349-362.
134. Wu, J.Y.; Johansen, F.F.; Lin, C.T.; Liu, J.W. Taurine system in the normal and ischemic rat hippocampus. Adv. Exp. Med. Biol. 1987, 217, 265-274.
135. Trenkner, E. The role of taurine and glutamate during early postnatal cerebellar development of normal and Weaver mutant mice. Adv. Exp. Med. Biol. 1990, 268, 239-244.
136. Tang, X.W.; Deupree, D.L.; Sun, Y.; Wu, J.Y. Biphasic effect of taurine on excitatory amino acid-induced neurotoxicity. Adv. Exp. Med. Biol. 1996, 403, 499-505.
137. Wu, J.; Chen, W.; Tang, X.W.; Jin, H.; Foos, T.; Schloss, J.V.; Davis, K.; Faiman, M.D.; Hsu, C. Mode of Action of Taurine and regulation Dynamics of Its Synthesis in the CNS. Adv. Exp. Med. Biol. 2000, 483, 35-44.
138. Wu, J.-Y.; Wu, H.; Jin, Y.; Wei, J.; Sha, D.; Prentice, H.; Lee, H.-H.; Lin, C.-H.; Lee, Y.-H.; Yang, L.-L. Mechanism of neuroprotective function of taurine. Adv. Exp. Med. Biol. 2009, 643, 169-179.
139. Chen, W. Mode of Action of Taurine. Ph. D Thesis, University of Kansas, Lawrence, KS, USA, 2000.
140. Schurr, A.; Tseng, M.T.; West, C.A.; Rigor, B.M. Taurine improves the recovery of neuronal function following cerebral hypoxia: An in vitro study. Life Sci. 1987, 40, 2059-2066.
141. Ricci, L.; Valoti, M.; Sgaragli, G.; Frosini, M. Protection by taurine of rat brain cortical slices against oxygen glucose deprivation-and reoxygenation-induced damage. Eur. J. Pharmacol. 2009, 621, 26-32.
142. Zhao, P.; Huang, Y.L.; Cheng, J.S. Taurine antagonizes calcium overload induced by glutamate or chemical hypoxia in cultured rat hippocampal neurons. Neurosci. Lett. 1999, 268, 25-28.
143. Wang, G.-H.; Jiang, Z.-L.; Fan, X.-J.; Zhang, L.; Li, X.; Ke, K.-F. Neuroprotective effect of taurine against focal cerebral ischemia in rats possibly mediated by activation of both GABAA and glycine receptors. Neuropharmacology 2007, 52, 1199-1209.
144. Molchanova, S.M.; Oja, S.S.; Saransaari, P. Taurine attenuates D-[3H]aspartate release evoked by depolarization in ischemic corticostriatal slices. Brain Res. 2006, 1099, 64-72.
145. Nicholls, D.G. Mitochondrial calcium function and dysfunction in the central nervous system. Biochim. Biophys. Acta 2009, 1787, 1416-1424.
146. Brustovetsky, N.; Brustovetsky, T.; Jemmerson, R.; Dubinsky, J.M. Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. J. Neurochem. 2002, 80, 207-218.
147. Bernardi, P.; Krauskopf, A.; Basso, E.; Petronilli, V.; Blachly-Dyson, E.; Blalchy-Dyson, E.; Di Lisa, F.; Forte, M.A. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J. 2006, 273, 2077-2099.
148. Jemmerson, R.; Dubinsky, J.M.; Brustovetsky, N. Cytochrome C release from CNS mitochondria and potential for clinical intervention in apoptosis-mediated CNS diseases. Antioxid. Redox Signal. 2005 7, 1158-1172.
149. Dedkova, E.N.; Ji, X.; Lipsius, S.L.; Blatter, L.A. Mitochondrial calcium uptake stimulates nitric oxide production in mitochondria of bovine vascular endothelial cells. Am J. Physiol. Cell Physiol. 2004, 286, 406-415.
150. Ottersen, O.P. Quantitative assessment of taurine-like immunoreactivity in different cell types and processes in rat cerebellum: An electronmicroscopic study based on a postembedding immunogold labelling procedure. Anat. Embryol. 1988, 178, 407-421.
151. Lobo, M. V; Alonso, F.J.; Martin del Rio, R. Immunocytochemical localization of taurine in different muscle cell types of the dog and rat. Histochem. J. 2000, 32, 53-61.
152. Bollard, M.E.; Murray, A.J.; Clarke, K.; Nicholson, J.K.; Griffin, J.L. A study of metabolic compartmentation in the rat heart and cardiac mitochondria using high-resolution magic angle spinning 1H NMR spectroscopy. FEBS Lett. 2003, 553, 73-78.
153. 2+ sequestration by taurine. Biochem. Pharmacol. 1999, 58, 1123-1131.
154. Hansen, S.H.; Andersen, M.L.; Birkedal, H.; Cornett, C.; Wibrand, F. The important role of taurine in oxidative metabolism. Adv. Exp. Med. Biol. 2006, 583, 129-135.
155. Chen, K.; Zhang, Q.; Wang, J.; Liu, F.; Mi, M.; Xu, H.; Chen, F.; Zeng, K. Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction. Brain Res. 2009, 1279, 131-138.
156. Hansen, S.H.; Andersen, M.L.; Cornett, C.; Gradinaru, R.; Grunnet, N. A role for taurine in mitochondrial function. J. Biomed. Sci. 2010, 17, S23.
157. Suzuki, T.; Suzuki, T.; Wada, T.; Saigo, K.; Watanabe, K. Taurine as a constituent of mitochondrial tRNAs: New insights into the functions of taurine and human mitochondrial diseases. EMBO J. 2002, 21, 6581-6589.
158. Yasukawa, T.; Suzuki, T.; Ueda, T.; Ohta, S.; Watanabe, K. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J. Biol. Chem. 2000, 275, 4251-4257.
159. Suzuki, T.; Nagao, A.; Suzuki, T. Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs. Wiley Interdiscip. Rev. RNA 2011, 2, 376-386.
160. Rikimaru, M.; Ohsawa, Y.; Wolf, A.M.; Nishimaki, K.; Ichimiya, H.; Kamimura, N.; Nishimatsu, S. Taurine Ameliorates Impaired the Mitochondrial Function and Prevents Stroke-like Episodes in Patients with MELAS. Intern. Med. 2012, 51, 3351-3357.
161. Thornberry, N.A. Caspases: Enemies Within. Science 1998, 281, 1312-1316.
162. Endres, M.; Namura, S.; Shimizu-Sasamata, M.; Waeber, C.; Zhang, L.; Gómez-Isla, T.; Hyman, B.T.; Moskowitz, M.A. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. 1998, 18, 238-247.
163. Rami, A.; Agarwal, R.; Botez, G.; Winckler, J. μ-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage. Brain Res. 2000, 866, 299-312.
164. Love, S. Apoptosis and brain ischaemia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27, 267-282.
165. Kambe, A.; Yokota, M.; Saido, T.C.; Satokata, I.; Fujikawa, H.; Tabuchi, S.; Kamitani, H.; Watanabe, T. Spatial resolution of calpain-catalyzed proteolysis in focal cerebral ischemia. Brain Res. 2005, 1040, 36-43.
166. Han, F.; Shirasaki, Y.; Fukunaga, K. 3-[2-[4-(3-Chloro-2-methylphenylmethyl)-1-piperazinyl] ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydro-chloride 3.5 hydrate (DY-9760e) is neuroprotective in rat microsphere embolism: Role of the cross-talk between calpain and caspase-3 through calpastatin. J. Pharmacol. Exp. Ther. 2006, 317, 529-536.
167. Goll, D.E.; Thompson, V.F.; Li, H.; Wei, W.; Cong, J. The Calpain System. Physiol. Rev. 2003, 1990, 731-801.
168. Wang, K.K. Calpain and caspase: Can you tell the difference? Trends Neurosci. 2000, 23, 20-26.
169. Ling, Y.-H.; Liebes, L.; Ng, B.; Buckley, M.; Elliott, P.J.; Adams, J.; Jiang, J.-D.; Muggia, F.M.; Perez-Soler, R. PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G2-M Phase Arrest and Apoptosis. Mol. Cancer Ther. 2002, 1, 841-849.
170. Nakagawa, T.; Yuan, J. Cross-Talk between Two Cysteine Protease Families: Activation of Caspase-12 by Calpain in Apoptosis. J. Cell Biol. 2000, 150, 887-894.
171. Gao, G.; Dou, Q.P. N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome c release and apoptotic cell death. J. Cell Biochem. 2000, 80, 53-72.
172. Castro, R.E.; Solá, S.; Ramalho, R.M.; Steer, C.J.; Rodrigues, C.M.P. The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons. J. Pharmacol. Exp. Ther. 2004, 311, 845-852.
173. Gil-Parrado, S.; Fernández-Montalván, A.; Assfalg-Machleidt, I.; Popp, O.; Bestvater, F.; Holloschi, A.; Knoch, T.A.; Auerswald, E.A.; Welsh, K.; Reed, J.C.; et al. Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. J. Biol. Chem. 2002, 277, 27217-27226.
174. Salvesen, G.S.; Dixit, V.M. Caspases: Intracellular Signaling by Proteolysis. Cell 1997, 91, 443-446.
175. Li, P.; Nijhawan, D.; Budihardjo, I.; Srinivasula, S.M.; Ahmad, M.; Alnemri, E.S.; Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91, 479-489.
176. Takatani, T.; Takahashi, K.; Uozumi, Y.; Shikata, E.; Yamamoto, Y.; Ito, T.; Matsuda, T.; Schaffer, S.W.; Fujio, Y.; Azuma, J. Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome. Am. J. Physiol. Cell Physiol. 2004, 287, 949-953.
177. Sun, M.; Xu, C. Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia. Cell Mol. Neurobiol. 2008, 28, 593-611.
178. Sun, M.; Gu, Y.; Zhao, Y.; Xu, C. Protective functions of taurine against experimental stroke through depressing mitochondria-mediated cell death in rats. Amino Acids 2011, 40, 1419-1429.
179. Taranukhin, A.G.; Taranukhina, E.Y.; Saransaari, P.; Djatchkova, I.M.; Pelto-Huikko, M.; Oja, S.S. Taurine reduces caspase-8 and caspase-9 expression induced by ischemia in the mouse hypothalamic nuclei. Amino Acids 2008, 34, 169-174.
180. Kumar, R.; Azam, S.; Sullivan, J.M.; Owen, C.; Cavener, D.R.; Zhang, P.; Ron, D.; Harding, H.P.; Chen, J.-J.; Han, A.; et al. Brain ischemia and reperfusion activates the eukaryotic initiation factor 2α kinase, PERK. J. Neurochem. 2001, 77, 1418-1421.
181. Azfer, A.; Niu, J.; Rogers, L.M.; Adamski, F.M.; Kolattukudy, P.E. Activation of endoplasmic reticulum stress response during the development of ischemic heart disease. Am. J. Physiol. Heart Circ. Physiol. 2006, 291, 1411-1420.
182. Kuznetsov, G.; Brostrom, M.; Brostrom, C. Demonstration of a calcium requirement for secretory protein processing and export. Differential effects of calcium and dithiothreitol. J. Biol. Chem. 1992, 267, 3932-3939.
183. Verkhratsky, A.; Toescu, E.C. Endoplasmic reticulum Ca(2+) homeostasis and neuronal death. J. Cell. Mol. Med. 2003, 7, 351-361.
184. Pizzo, P.; Pozzan, T. Mitochondria-endoplasmic reticulum choreography: Structure and signaling dynamics. Trends Cell Biol. 2007, 17, 511-517.
185. Morimoto, N.; Oida, Y.; Shimazawa, M.; Miura, M.; Kudo, T.; Imaizumi, K.; Hara, H. Involvement of endoplasmic reticulum stress after middle cerebral artery occlusion in mice. Neuroscience 2007, 14, 957-967.
186. Malhotra, J.D.; Kaufman, R.J. The endoplasmic reticulum and the unfolded proteinresponse. Semin. Cell Dev. Biol. 2007, 18, 716-731.
187. Rao, R.V.; Bredesen, D.E. Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr. Opin. Cell Biol. 2004, 16, 653-662.
188. Ron, D.; Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 2007, 8, 519-529.
189. Chakrabarti, A.; Chen, A.W.; Varner, J.D. A review of the mammalian unfolded protein response. Biotechnol. Bioeng. 2011, 108, 2777-2793.
190. Gharibani, P.M.; Modi, J.; Pan, C.; Menzie, J.; Ma, Z.; Chen, P.C.; Tao, R.; Prentice, H.; Wu, J.Y. The Mechanism of Taurine Protection Against Endoplasmic recticulum Stress in an Animal Stroke Model of Cerebral Artery Occlusion and Stroke-Related Conditions in Primary Neuronal Cell Culture. Adv. Exp. Med. Biol. 2013, 776, 241-258.
191. Ghosh, A.P.; Klocke, B.J.; Ballestas, M.E.; Roth, K.A. CHOP potentially co-operates with FOXO3a in neuronal cells to regulate PUMA and BIM expression in response to ER stress. PLoS One 2012, 7, e39586.
192. McCullough, K.D.; Martindale, J.L.; Klotz, L.O.; Aw, T.Y.; Holbrook, N.J. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell. Biol. 2001, 21, 1249-1259.
193. Schuller-Levis, G.B.; Park, E. Taurine and Its Chloramine: Modulators of Immunity. Neurochem Res. 2004, 29, 117-126.
194. Halliwell, B. Reactive oxygen species and the central nervous system. J. Neurochem. 1992, 59, 1609-1623.
195. Zini, I.; Tomasi, A.; Grimaldi, R.; Vannini, V.; Agnati, L.F. Detection of free radicals during brain ischemia and reperfusion by spin trapping and microdialysis. Neurosci. Lett. 1992, 138, 279-282.
196. Sohal, R.S.; Orr, W.C. Relationship between antioxidants, prooxidants, and the aging process. Ann. N. Y. Acad. Sci. 1992, 663, 74-84.
197. Turrens, J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552, 335-344.
198. Brookes, P.S.; Darley-Usmar, V.M. Role of calcium and superoxide dismutase in sensitizing mitochondria to peroxynitrite-induced permeability transition. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, 39-46.
199. Wikström, M.; Saari, H. A spectral shift in cytochrome a induced by calcium ions. Biochim. Biophys. Acta 1975, 408, 170-179.
200. Jekabsone, A.; Ivanoviene, L.; Brown, G.C.; Borutaite, V. Nitric oxide and calcium together inactivate mitochondrial complex I and induce cytochrome c release. J. Mol. Cell. Cardiol. 2003, 35, 803-809.
201. 2+-stimulated generation of reactive oxygen species by the respiratory chain. Biochemistry 1999, 38, 13279-13287.
202. Cleeter, M.W.; Cooper, J.M.; Darley-Usmar, V.M.; Moncada, S.; Schapira, A.H. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 1994, 345, 50-54.
203. 2+. J. Biol. Chem. 2004, 279, 4166-4174.
204. Patterson, S.D.; Spahr, C.S.; Daugas, E.; Susin, S.A.; Irinopoulou, T.; Koehler, C.; Kroemer, G. Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition. Cell Death Differ. 2000, 7, 137-144.
205. Ricci, C.; Pastukh, V.; Leonard, J.; Turrens, J.; Wilson, G.; Schaffer, D.; Schaffer, S.W. Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. Am. J. Physiol. 2008, 294, 413-422.
206. Mochizuki, H.; Oda, H.; Yokogoshi, H. Dietary taurine alters ascorbic acid metabolism in rats fed diets containing polychlorinated biphenyls. J. Nutr. 2000, 130, 873-876.
207. Vohra, B.P.; Hui, X. Taurine protects against carbon tetrachloride toxicity in the cultured neurons and in vivo. Arch. Physiol. Biochem. 2001, 109, 90-94.
208. Balkan, J.; Kanbaǧli, O.; Aykaç-Toker, G.; Uysal, M. Taurine treatment reduces hepatic lipids and oxidative stress in chronically ethanol-treated rats. Biol. Pharm. Bull. 2002, 25, 1231-1233.
209. Mahalakshmi, K.; Pushpakiran, G.; Anuradha, C.V. Taurine prevents acrylonitrile-induced oxidative stress in rat brain. Pol. J. Pharmacol. 2003, 55, 1037-1043.
210. Pushpakiran, G.; Mahalakshmi, K.; Anuradha, C.V. Taurine restores ethanol-induced depletion of antioxidants and attenuates oxidative stress in rat tissues. Amino Acids 2004, 27, 91-96.
211. Aruoma, O.I.; Halliwell, B.; Hoey, B.M.; Butler, J. The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem. J. 1988, 256, 251-255.
212. Jong, C.J.; Azuma, J.; Schaffer, S. Mechanism underlying the antioxidant activity of taurine: Prevention of mitochondrial oxidant production. Amino Acids 2012, 42, 2223-2232.
213. Jong, C.J.; Ito, T.; Mozaffari, M.; Azuma, J.; Schaffer, S. Effect of beta-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content. J. Biomed. Sci. 2010, 17, S25.
214. Amantea, D.; Nappi, G.; Bernardi, G.; Bagetta, G.; Corasaniti, M.T. Post-ischemic brain damage: Pathophysiology and role of inflammatory mediators. FEBS J. 2009, 276, 13-26.
215. Koh, S.-H.; Chang, D.-I.; Kim, H.-T.; Kim, J.; Kim, M.-H.; Kim, K. S.; Bae, I.; Kim, H.; Kim, D.W.; Kim, S.H. Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model. Toxicology 2005, 214, 131-139.
216. Haddad, M.; Rhinn, H.; Bloquel, C.; Coqueran, B.; Szabó, C.; Plotkine, M.; Scherman, D.; Margaill, I. Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br. J. Pharmacol. 2006, 149, 23-30.
217. Sun, M.; Zhao, Y.-M.; Gu, Y.; Xu, C. Therapeutic window of taurine against experimental stroke in rats. Transl. Res. 2012, 160, 223-229.
218. Walz, W.; Klimaszewski, A.; Paterson, I.A. Glial swelling in ischemia: A hypothesis. Dev. Neurosci. 1993, 15, 216-225.
219. Haugstad, T.S.; Langmoen, I.A. Release of brain amino acids during hyposmolar stress and energy deprivation. J. Neurosurg. Anesthesiol. 1996, 8, 159-168.
220. Saransaari, P.; Oja, S.S. Taurine release is enhanced in cell-damaging conditions in cultured cerebral cortical astrocytes. Neurochem. Res. 1999, 24, 1523-1529.
221. Estevez, A.Y.; O'Regan, M.H.; Song, D.; Phillis, J.W. Hyposmotically induced amino acid release from the rat cerebral cortex: Role of phospholipases and protein kinases. Brain Res. 1999, 844, 1-9.
222. Inoue, H.; Mori, S.-I.; Morishima, S.; Okada, Y. Volume-sensitive chloride channels in mouse cortical neurons: Characterization and role in volume regulation. Eur. J. Neurosci. 2005, 21, 1648-1658.
223. Molchanova, S.M.; Oja, S.S.; Saransaari, P. Properties of basal taurine release in the rat striatum in vivo. Adv. Exp. Med. Biol. 2006, 583, 365-375.
224. Inoue, H.; Okada, Y. Roles of volume-sensitive chloride channel in excitotoxic neuronal injury. J. Neurosci. 2007, 27, 1445-1455.
225. Shuaib, A. The role of taurine in cerebral ischemia: Studies in transient forebrain ischemia and embolic focal ischemia in rodents. Adv. Exp. Med. Biol. 2003, 526, 421-431.
226. Kudo, Y.; Akiyoshi, E.; Akagi, H. Identification of two taurine receptor subtypes on the primary afferent terminal of frog spinal cord. Br. J. Pharmacol. 1988, 94, 1051-1056.
227. Sanberg, P.R.; Willow, M. Dose-dependent effects of taurine on convulsions induced by hypoxia in the rat. Neurosci Lett. 1980, 16, 297-300.
228. Stummer, W.; Betz, A.L.; Shakui, P.; Keep, R.F. Blood-brain barrier taurine transport during osmotic stress and in focal cerebral ischemia. J. Cereb. Blood Flow. Metab. 1995, 15, 852-859.
229. Azuma, J.; Sawamura, A.; Awata, N.; Ohta, H.; Hamaguchi, T.; Haradam, H.; Takiharma, K.; Hasegawa, H.; Yamagami, T.; Ishiyama, T.; et al. Therapeutic Effect of Taurine in Congestive Heart Failure: A Double-Blind Crossover Trial. Clin. Cardiol. 1985, 8, 276-282.
230. Azuma, J.; Sawamura, A.; Awata, N. Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn. Circ. J. 1992, 56, 95-99.
231. Yamori, Y.; Nara, Y.; Mizushima, S.; Sawamura, M.; Horie, R. Nutritional factors for stroke and major cardiovascular diseases: International epidemiological comparison of dietary prevention. Health Rep. 1994, 6, 22-27.
232. Jeejeebhoy, F.; Keith, M.; Freeman, M.; Barr, A.; McCall, M.; Kudan, R.; Mazer, D.; Errett, L. Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular dysfunction. Am. Heart J. 2002, 143, 10092-10100.
233. Kingston, R.; Kelly, C.J.; Murray, P. The therapeutic role of taurine in ischaemia-reperfusion injury. Curr. Pharm. Des. 2004, 10, 2401-2410.
234. Fisher, M.; Feuerstein, G.; Howells, D.W.; Hurn, P.D.; Kent, T.A.; Savitz, S.I.; Lo, E.H.; STAIR Group. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009, 40, 2244-2250.
235. Kanthan, R.; Shuaib, A.; Griebel, R.; Miyashita, H. Intracerebral human microdialysis. In vivo study of an acute focal ischemic model of the human brain. Stroke 1995, 26, 870-873.
236. Zhang, M.; Bi, L.F.; Fang, J.H.; Su, X.L.; Da, G.L.; Kuwamori, T.; Kagamimori, S. Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 2004, 26, 267-271.
237. Takahashi, H.; Mori, T.; Fujihira, E.; Nakazawa, M. Long-term feeding of taurine in rats. Pharmacometrics 1972, 6, 529-534.
238. Takahashi, H.; Kaneda, S.; Fukuda, K.; Fujihira, E.; Nakazawa, M. Studies on the teratology and three generation reproduction of taurine in mice. Pharmacometrics 1972, 6, 535-540.
239. Sturman, J.A.; Messing, J.M. High dietary taurine effects on feline tissue taurine concentrations and reproductive performance. J. Nutr. 1992, 122, 82-88.
240. Furukawa, S.; Katto, M.; Kouyama, H.; Nishida, I.; Kikumori, M.; Taniguchi, Y.; Toda, T.; Araki, H. Repeated dose toxicity study of intravenous treatment with taurine for 13 weeks and recovery test for 5 weeks in rat. Jpn. Pharmacol. Ther. 1991, 19, 275-306.
241. Cantafora, A.; Mantovani, A.; Masella, R.; Mechelli, L.; Alvaro, D. Effect of taurine administration on liver lipids in guinea pig. Experientia 1986, 42, 407-408.
242. European Food Safety Authority (EFSA). EFSA adopts opinion on two ingredients commonly used in some energy drinks, 2009. Avaiable onlin: http://www.efsa.europa.eu/en/press/news/ ans090212.htm (accessed on 15 February 2013).
243. Schaffer, S.; Takahashi, K.; Azuma, J. Role of osmoregulation in the actions of taurine. Amino Acids 2000, 19, 527-546.
244. Morales, I.; Dopico, J.G.; Sabate, M.; Gonzalez-Hernandez, T.; Rodriguez, M. Substantia nigra osmoregulation: Taurine and ATP involvement. Am. J. Physiol. Cell Physiol. 2007, 292, 1934-1941.
245. O'Byrne, M.B.; Tipton, K.F. Taurine-induced attenuation of MPP+ neurotoxicity in vitro: A possible role for the GABA(A) subclass of GABA receptors. J. Neurochem. 2000, 74, 2087-2093.
246. Paula-Lima, A.C.; de Felice, F.G.; Brito-Moreira, J.; Ferreira, S.T. Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons. Neuropharmacology 2005, 49, 1140-1148.
247. Chen, P.C.; Pan, C.; Gharibani, P.M.; Prentice, H.; Wu, J.Y. Taurine exerts robust protection against hypoxia and oxygen/glucose deprivation in human neuroblastoma cell culture. Adv. Exp. Med. Biol. 2013, 775, 167-175.
248. Das, J.; Ghosh, J.; Manna, P.; Sil, P.C. Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK. Biochem. Pharmacol. 2011, 81, 891-909.
249. Smith, K.E.; Borden, L.A.; Wang, C.H.; Hartig, P.R.; Branchek, T.A.; Weinshank, R.L. Cloning and expression of a high affinity taurine transporter from rat brain. Mol. Pharmacol. 1992, 42, 563-569.
250. Pow, D.V.; Sullivan, R.; Reye, P.; Hermanussen, S. Localization of taurine transporters, taurine, and (3)H taurine accumulation in the rat retina, pituitary, and brain. Glia 2002, 37, 153-168.
251. Wu, J.Y.; Liao, C.C.; Lin, C.J.; Lee, Y.H.; Ho, J.Y.; Tsai, W.H. Taurine receptor in the mammalian brain. Prog. Clin. Biol. Res. 1990, 351, 147-156.
252. López-Colomé, A.M.; Fragoso, G.; Salceda, R. Taurine receptors in membranes from retinal pigment epithelium cells in culture. Neuroscience 1991, 41, 791-796.
253. Sung, D.-Y.; Walthall, W.W.; Derby, C.D. Identification and partial characterization of putative taurine receptor proteins from the olfactory organ of the spiny lobster. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 1996, 115, 19-26.
254. Anderson, P.A.; Trapido-Rosenthal, H.G. Physiological and chemical analysis of neurotransmitter candidates at a fast excitatory synapse in the jellyfish Cyanea capillata (Cnidaria, Scyphozoa). Invert. Neurosci. 2009, 9, 167-173.